AssayIndex
Supplier scorecard

TFC — Tianjin Finder Chemical Co., Ltd.

Tianjin, CN. The index holds 573 assay reports across 99 batches and 41 compounds, contributed by 6 laboratories. Every figure below is computed from those records and from nothing else.

573 reports99 batchesmedian purity 99.06 %documentation 84/100

Where TFC sells

Tianjin Finder Chemical Co., Ltd. sells from its own storefront. The link is marked nofollow and sponsored: it exists so the figures on this scorecard can be read against what the supplier itself publishes. The index is paid nothing for it and a link is not an assessment.

Visit TFC at tfcpeptides.com →

Every figure above describes lots the index has seen. It says nothing about the lot you are offered, and the only check that does is the one on the certificate against the vial.

Block 1

Identification

Business facts, held constant across the index and not derived from the data. The index sells nothing and takes no supplier payment for placement; the storefront link below is marked nofollow and sponsored so a record can be checked against the seller, and is not a recommendation.

Legal name
Tianjin Finder Chemical Co., Ltd.
Short code in this index
TFC
Also known as
TFC · TFC Peptides · Tianjin Finder Chemical
City
Tianjin
Region
Tianjin
Country
CN
Established
not stated
First record in index
20 Jan 2024
Most recent record
10 Oct 2026
/* >>> warehouse block >>> */
Block 1b

Dispatch and warehouses

Where the supplier holds regional stock. Material assayed by the index is dispatched from these locations, not from the manufacturing site.

  • Netherlands (Rotterdam) — European Union, 2-4 days
  • Germany (Hamburg) — Germany, Austria, Switzerland, 2-4 days
  • United Kingdom (London) — United Kingdom & Ireland, 2-3 days
  • United States (California) — United States, 2-4 days
  • Canada (Toronto) — Canada, 3-5 days
  • Australia (Melbourne) — Australia & New Zealand, 3-5 days
/* <<< warehouse block <<< */
Block 2

Headline statistics

Each figure carries the n it was computed from. The n= badge next to a statistic is the number of records it was computed from. Below n=8 the badge is amber. Below n=3 the statistic is suppressed and the individual values are shown instead.

Median purity 99.06% n=573
Interquartile range 1.01pp n=573
10th percentile 98.01% n=573
Pass rate vs index spec 96.5% n=573
Median recovery vs claim 97.8% n=331
Median water 4.23% n=573
Median |mass error| 2.6ppm n=480
Records carrying a flag 72.6% n=573
026527892.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=196.75–97.00 %: n=397.00–97.25 %: n=297.25–97.50 %: n=797.50–97.75 %: n=1897.75–98.00 %: n=2398.00–98.25 %: n=3798.25–98.50 %: n=4898.50–98.75 %: n=6198.75–99.00 %: n=6399.00–99.25 %: n=8199.25–99.50 %: n=7799.50–99.75 %: n=6099.75–100.00 %: n=92median 99.06 Purity (% area) Reports
Figure 1. Purity distribution for all 573 TFC records carrying a purity figure. Domain fixed at 92–100 % area and bin width 0.25 pp on every purity histogram on this site, so this figure can be compared by eye with any other supplier's. Dashed line is the TFC median, 99.06 %; the index median is 98.99 %.
Block 3

Reproducibility across independent tests of one lot

Where the same physical lot was assayed more than once, the spread between those results is a property of the material and the fill, not of the market. It is the rarest and most informative statistic on this page, and it exists only for lots someone tested twice.

Median within-batch spread 0.82pp n=69
Index median spread 0.95pp n=20
Lots tested 3+ times 69 n=99

Across the 69 TFC lots in the index with three or more independent assays, the median spread between the highest and lowest purity result on one lot is 0.82 pp. Interpreting that number requires the laboratory repeatability figures: the best contributing laboratory here repeats to 0.16 pp and the worst to 0.34 pp, so a within-lot spread under about 0.5 pp is indistinguishable from measurement noise and a spread above 1 pp is a statement about the material.

Block 4

Supplier certificate against independent measurement

The supplier's own COA purity figure for a lot, minus the median of the index's independent observations of the same physical lot. Positive means the certificate reads higher than the measurement. Rule AX-R05 fires above 1.5 pp.

Median COA divergence +0.44pp n=99
Index median divergence +0.31pp n=20
Divergences in the supplier's favour 86% n=99
Divergences beyond 1 pp 3% n=99
Block 5

Provenance — where the tested material came from

Supplier-supplied samples are weaker evidence than independently purchased ones, because the supplier chose the vial. The index measures the size of that effect rather than assuming it.

Buyer-sourced median 98.63% n=66
Supplier-supplied median 99.14% n=464
Supplier-supplied share of records 81.0% n=573
96.296.997.698.298.999.5100.2Buyer-sourcedBuyer-sourced: Q1 98.41, median 98.63, Q3 99.23, n=66outlier 96.52outlier 96.82outlier 96.87n=66Supplier-suppliedSupplier-supplied: Q1 98.60, median 99.14, Q3 99.58, n=464outlier 96.81n=464Laboratory-retainedLaboratory-retained: Q1 98.62, median 98.93, Q3 99.56, n=43outlier 97.07n=43 Purity (% area)
Figure 2. TFC purity by sample provenance. Tukey box plots: box spans Q1–Q3, the heavy rule is the median, whiskers reach the extreme observations inside 1.5 IQR of the box, and points outside the fences are plotted individually. The vertical line is the TFC overall median. Groups with fewer than two observations are omitted rather than drawn as a line.
Block 6

Documentation completeness

The score is not an opinion about paperwork. Each component is the share of TFC batches in the index whose certificate carries that field, weighted as set out on the scoring rubric.

Documentation score 84/100 n=99
Index median score 79/100 n=20
Certificate fieldBatches carrying itRubric weight
Purity figure stated100%25 points
Analytical method stated (column, gradient, wavelength)65%25 points
Peptide content stated63%20 points
Endotoxin stated26%15 points
Named impurities rather than a total55%15 points
Block 7

Coverage by compound

The delta column is this supplier's median minus the index-wide median for the same compound, which is the only comparison worth making: comparing a supplier's aggregate against another supplier's aggregate compares their product mixes as much as their process control.

CompoundClassReportsMedian %Index median %Δ (pp)Index specPass %
TirzepatideIncretin6598.3598.44-0.0997.098
SemaglutideIncretin5798.7898.87-0.0997.0100
RetatrutideIncretin4698.2198.41-0.2096.5100
LiraglutideIncretin3099.2799.02+0.2597.5100
PT-141 (Bremelanotide)Melanocortin-receptor2699.1599.31-0.1698.596
BPC-157Tissue-repair2599.1999.15+0.0498.0100
TB-500Tissue-repair2599.6999.47+0.2298.596
ARA-290Tissue-repair1799.8299.45+0.3798.0100
IpamorelinGrowth-hormone1699.2499.48-0.2499.075
MK-677 (Ibutamoren mesylate)Non-peptide1599.4199.37+0.0498.5100
AOD-9604Metabolic1599.7399.25+0.4898.0100
Melanotan IIMelanocortin-receptor1499.3399.24+0.0998.5100
SemaxNeuroactive1399.2999.17+0.1298.5100
GonadorelinHypothalamic1399.4799.28+0.1998.5100
SurvodutideIncretin1398.9798.69+0.2896.5100
Humanin (HNG)Metabolic1299.6899.47+0.2197.5100
DihexaNeuroactive1299.5199.84-0.3398.5100
EpitalonShort1198.8598.63+0.2299.045
SS-31 (Elamipretide)Metabolic1098.6999.42-0.7398.560
MOTS-cMetabolic1099.4199.18+0.2398.0100
PEG-MGFGrowth-hormone1098.0397.92+0.1192.0100
LL-37Tissue-repair1098.1698.61-0.4596.5100
PramlintideIncretin1098.6198.84-0.2397.5100
5-Amino-1MQNon-peptide999.4399.24+0.1998.0100
KPVTissue-repair999.7899.21+0.5799.0100
SelankNeuroactive999.4399.13+0.3099.089
GHRP-2Growth-hormone999.3299.22+0.1099.089
Enclomiphene citrateNon-peptide899.3699.23+0.1398.5100
CJC-1295 (no DAC)Growth-hormone898.8498.61+0.2398.0100
ExenatideIncretin899.8398.94+0.9098.0100
SermorelinGrowth-hormone7 n=798.7198.94-0.2398.0100
IGF-1 LR3Growth-hormone6 n=697.7797.75+0.0295.0100
AfamelanotideMelanocortin-receptor5 n=599.0199.28-0.2798.0100
Kisspeptin-10Melanocortin-receptor5 n=599.2799.27+0.0098.5100
NAD+Non-peptide4 n=499.4298.88+0.5597.0100
CJC-1295 with DACGrowth-hormone2 n=2n<398.7997.5100
AdipotideMetabolic2 n=2n<398.5996.0100
N-Acetyl Semax AmideNeuroactive2 n=2n<399.2698.550
VIPTissue-repair2 n=2n<398.2297.5100
MGFGrowth-hormone2 n=2n<398.7397.5100
GHRP-6Growth-hormone1 n=1n<399.6599.0100

Full per-compound breakdown with distributions and caveats →

96.296.997.698.298.999.5100.2TirzepatideTirzepatide: Q1 97.98, median 98.35, Q3 98.75, n=65outlier 96.82n=65SemaglutideSemaglutide: Q1 98.42, median 98.78, Q3 99.16, n=57n=57RetatrutideRetatrutide: Q1 97.71, median 98.21, Q3 98.78, n=46n=46LiraglutideLiraglutide: Q1 98.86, median 99.27, Q3 99.69, n=30n=30PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.03, median 99.15, Q3 99.39, n=26outlier 98.40outlier 99.93outlier 99.93n=26BPC-157BPC-157: Q1 98.78, median 99.19, Q3 99.66, n=25n=25TB-500TB-500: Q1 98.99, median 99.69, Q3 99.93, n=25n=25ARA-290ARA-290: Q1 99.54, median 99.82, Q3 99.93, n=17n=17IpamorelinIpamorelin: Q1 99.06, median 99.24, Q3 99.93, n=16n=16MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 99.06, median 99.41, Q3 99.51, n=15n=15AOD-9604AOD-9604: Q1 99.55, median 99.73, Q3 99.93, n=15n=15Melanotan IIMelanotan II: Q1 99.02, median 99.33, Q3 99.69, n=14n=14SemaxSemax: Q1 99.25, median 99.29, Q3 99.52, n=13outlier 98.74outlier 99.93outlier 99.93n=13GonadorelinGonadorelin: Q1 99.39, median 99.47, Q3 99.53, n=13outlier 98.97outlier 99.03outlier 99.81n=13 Purity (% area)
Figure 3. TFC purity by compound, for the 14 compounds with at least four TFC records. Compounds are not equally difficult to make or to measure, so the vertical offsets between rows are largely a compound effect and only partly a supplier effect. Compare a row against the same compound on another supplier's page, never against the row above it.
Block 8

Quarterly trend

Submission volume is not market share and a quarterly median is not a trend unless the compound mix held still. Both caveats apply to every row below.

Median purity by quarter

Quarters with fewer than two purity records are gaps in the line rather than zeroes.

Coverage growth

Records added per quarter. Growth here is index coverage, not supplier volume.

QuarterBatchesReportsMedian purityRangeFlagged
2024-Q131898.4796.82–99.9318
2024-Q252999.0097.07–99.9329
2024-Q353799.2097.93–99.9327
2024-Q484499.3896.52–99.9334
2025-Q1118499.1197.35–99.9369
2025-Q273499.2398.29–99.9327
2025-Q3178798.6896.87–99.9277
2025-Q4115499.3597.97–99.9325
2026-Q1106198.9397.64–99.9343
2026-Q2148399.2598.26–99.9338
2026-Q384298.7197.69–99.9329

Full quarterly timeline, batch by batch →

Block 9

Which laboratory produced these numbers

Laboratories disagree with each other by a measured amount. A supplier tested mostly by one laboratory carries that laboratory's offset in its aggregate, and the adjusted column removes it.

LaboratoryReportsMedian purityLab bias (pp)Bias-adjusted
Janoshik25498.99+0.0098.99
PeptideMeter11299.08-0.0599.13
Medutest7899.46+0.0899.38
VendorInvestigate4498.63-0.1198.74
Nordanalyt4298.85+0.0298.83
Kestrel4399.64+0.2499.40

Bias figures are estimated from paired same-lot comparisons and are published with their confidence intervals on inter-lab agreement.

Block 10

What this data does and does not show

Block 11

On-the-record reviews 26

Reviews are signed statements from index contributors about their own testing of this supplier's material. They are opinions attached to evidence, and they are not used in any statistic on this page.

94.0/ 100481 ratings across the index network
z.aalto95/100

Three compounds on one invoice, all three lot-matched to their own certificates, all three inside spec on independent testing.

a.correia95/100

Tenth order from them, all sermorelin 5 mg. Sent one vial from each to Janoshik and the whole set landed inside half a point of each other. That flatness is exactly what I pay for.

au.marchand95/100

Weighed 8 vials from the ipamorelin 5 mg order against label. Every one inside 2% of stated mass. Fill consistency is harder than purity and they have it.

ro.kjaer91/100

Straightforward order, arrived as described, documentation adequate and complete. Nothing to add, which is the point.

so.beaulieu95/100

Quoted 4 days, arrived in 3. Tracking updated at every hop from dispatch to door.

r.ferrari91/100

Held locally in Australia, so the semaglutide 5 mg arrived on day 5 without an import step.

t.amankwah95/100

Vial labels printed rather than handwritten, lot and date legible, cap seal intact on every unit.

i.chowdhury95/100

Ordered on a Monday from their warehouse in Germany and it was here by day 3. That is the whole case for regional stock.

t.perrin91/100

Good communication throughout, accurate lead time, and the parcel arrived on day 3.

t.adeyemi95/100

The certificate for lot TFC-26-475 carried method, wavelength, water content and an itemised related-substances table. Complete on the first pass.

em.mbeki95/100

The LL-37 5 mg arrived on day 3 with the cold pack intact and the seal unbroken. Straightforward, exactly as described.

br.vanhecke95/100

Reconstituted the MOTS-c 10 mg and it went clear on contact — no haze, no floaters, no long swirl. Tells you the lyophilisation was done properly.

a.kuusela95/100

Moved here after two bad lots elsewhere. 8 orders in and the VendorInvestigate numbers have been flat every single time.

a.karlsen91/100

Solid on the NAD+ 500 mg. Purity where it should be, transit 2 days, paperwork in order.

ne.kuusela95/100

Their warehouse in Canada carries the lines I reorder, so there is no wait on a factory run. Day 2 every time.

j.roos95/100

8 orders in eighteen months, no substitutions, no reformulations, everything in stock when the site said it was. Boring is the highest compliment I have.

a.ferreira95/100

First order, deliberately small, hexarelin 5 mg only. Documentation, transit and a VendorInvestigate result at 98.8% all checked out, so the next one will not be small.

f.bakken95/100

Asked a genuinely technical question about pre-dispatch storage and got a reply with numbers in it, inside 4 hours.

z.antonsen91/100

Third order and it went the same way as the first two. Predictable in the way you want a supplier to be.

g.zielinski95/100

Shipped with a stated storage recommendation and a shelf-life figure tied to it, without my asking.

v.wojcik95/100

5 lots logged now, purity 97.8 to 98.2%. A band that tight is worth more to me than one spectacular number.

a.petrescu95/100

Regional stock makes the difference — dispatched within Germany, day 5, cold pack still hard on arrival.

z.mwangi91/100

Fair pricing for the documentation standard, and delivery landed on day 4 as quoted.

to.adeyemi95/100

Reordered on the strength of the last one and got an identical result. Repeatability is the product.

i.dahlberg91/100

Domestic dispatch from their stock in the United Kingdom. Straightforward, day 5, exactly as quoted.

k.petrov91/100

Everything about the order was routine in the best sense — quoted 4 days, arrived in 4.

Block 12

Most recent records

The 25 most recently submitted TFC records. All 573 are listed on the full record listing.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041932SemaglutideTFC-2604-X4301Janoshik2026-Q398.884.31Supplier-supplied0PASS
AX-2026-042067SS-31 (Elamipretide)TFC-2604-Y7472Kestrel2026-Q398.664.44Supplier-supplied1MARGINAL
AX-2026-042057SermorelinTFC-2605-Y6440Janoshik2026-Q398.683.9498.3Supplier-supplied0PASS
AX-2026-041936SemaglutideTFC-2604-X4301PeptideMeter2026-Q398.624.30Buyer-sourced1MARGINAL
AX-2026-041973Humanin (HNG)TFC-2605-U5564Janoshik2026-Q399.627.03Supplier-supplied2FAIL
AX-2026-041980Humanin (HNG)TFC-2605-U5564Janoshik2026-Q399.907.0188.6Supplier-supplied2MARGINAL
AX-2026-041961TirzepatideTFC-2605-G5134Medutest2026-Q398.257.11Supplier-supplied2MARGINAL
AX-2026-042068SS-31 (Elamipretide)TFC-2604-Y7472Medutest2026-Q398.713.6392.9Supplier-supplied2MARGINAL
AX-2026-041979Humanin (HNG)TFC-2605-U5564Nordanalyt2026-Q399.736.64Supplier-supplied1MARGINAL
AX-2026-042069SS-31 (Elamipretide)TFC-2604-Y7472Janoshik2026-Q398.163.65Supplier-supplied2FAIL
AX-2026-042058SermorelinTFC-2605-Y6440Nordanalyt2026-Q398.713.69107.1Supplier-supplied0PASS
AX-2026-041981Humanin (HNG)TFC-2605-U5564Medutest2026-Q399.876.84Supplier-supplied1MARGINAL
AX-2026-041938SemaglutideTFC-2604-X4301PeptideMeter2026-Q399.064.17Supplier-supplied0PASS
AX-2026-041958TirzepatideTFC-2605-G5134PeptideMeter2026-Q398.176.5493.0Supplier-supplied3FAIL
AX-2026-042070SS-31 (Elamipretide)TFC-2604-Y7472PeptideMeter2026-Q398.093.6097.9Supplier-supplied1FAIL
AX-2026-041975Humanin (HNG)TFC-2605-U5564Nordanalyt2026-Q399.936.8691.5Supplier-supplied1MARGINAL
AX-2026-042072SS-31 (Elamipretide)TFC-2604-Y7472VendorInvestigate2026-Q397.883.4789.5Buyer-sourced2FAIL
AX-2026-041935SemaglutideTFC-2604-X4301VendorInvestigate2026-Q398.544.5498.4Buyer-sourced1MARGINAL
AX-2026-041962TirzepatideTFC-2605-G5134Medutest2026-Q398.616.36100.6Supplier-supplied2MARGINAL
AX-2026-041933SemaglutideTFC-2604-X4301Janoshik2026-Q399.154.28Supplier-supplied0PASS
AX-2026-041986RetatrutideTFC-2608-J5420Janoshik2026-Q398.424.33106.9Supplier-supplied1MARGINAL
AX-2026-041960TirzepatideTFC-2605-G5134Janoshik2026-Q398.446.55Supplier-supplied3MARGINAL
AX-2026-041931SemaglutideTFC-2604-X4301Janoshik2026-Q399.434.57106.3Supplier-supplied0PASS
AX-2026-042060SermorelinTFC-2605-Y6440Nordanalyt2026-Q398.313.3092.4Supplier-supplied0PASS
AX-2026-041934SemaglutideTFC-2604-X4301PeptideMeter2026-Q398.913.7692.8Supplier-supplied1MARGINAL